Dysfunctional circadian rhythms and mood disorders: Opportunities for novel therapeutic approaches

Modern Trends in Pharmacopsychiatry

Volumn 27, Issue , 2010, Pages 32-52

  Norman, Trevor R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 CYCLOHEXYL 5 (4 FLUORO PHENYL) 3H IMIDAZOL 4 YL] PYRIMIDIN 2 YLAMINE; AGOMELATINE; ANTIDEPRESSANT AGENT; GROWTH HORMONE; HYDROCORTISONE; MELATONIN; PF 670462; PROLACTIN; PROTEIN SERINE THREONINE KINASE INHIBITOR; THYROID HORMONE; UNCLASSIFIED DRUG;

BASAL BODY TEMPERATURE; BIPOLAR DISORDER; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; REM SLEEP; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP WAKING CYCLE;

EID: 78649674656     PISSN: 16622685     EISSN: 16624505     Source Type: Book Series    
DOI: 10.1159/000319500     Document Type: Review

References (117)

1. Wever RA: The Circadian System of Man: Results of Experiments under Temporal Isolation. New York, Springer, 1969.
2. Lewy AJ, Sack RL: Intensity, wavelength and timing: three critical parameters for chronobiologically active light; in Kupfer DJ, Monk TH, Barchas JD (eds): Biological Rhythms and Mental Disorders. New York, The Guilford Press, 1988.
3. Healy D: Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders. Psychopharmacology 1987;93:271-285.
4. Duncan WC: Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther 1996;71:253-312.
5. McIntyre IM, Norman TR, Marriott PF, Burrows GD: The pineal hormone melatonin in panic disorder. J Affect Disord 1987;12:203-206.
6. McIntyre IM, Morse C: Urinary 6-sulphatoxy melatonin levels within the menstrual cycle and in patients with premenstrual syndrome. Psychoneuroendocrinology 1990;15:233-236.
7. Benca RM, Obermeyer WH, Thisted RA, Gillin JC: Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 1992;49:651-668.
8. Gordijn MC, Beersma DG, Bouhuys AL, Reinink E, Van den Hoofdakker RH: A longitudinal study of diurnal mood variation in depression: characteristics and significance. J Affect Disord 1994;31:261-273.
9. Germain A, Kupfer DJ: Circadian rhythm disturbances in depression. Hum Psychopharmacol 2008;23:571-585.
10. Wirz-Justice A: Chronobiology and mood disorders. Dialogues Clin Neurosci 2003;5:315-325.
11. Wehr TA, Wirz-Justice A, Goodwin FK, Duncan W, Gillin JC: Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 1979;206:710-713.
12. Van den Hoofdakker RH: Chronobiological theories of non-seasonal affective disorders and their implications for treatment. J Biol Rhythms 1994;9:157-183.
13. Emens J, Lewy A, Kinzie JM, Arntz D, Rough J: Circadian misalignment in major depressive disorder. Psychiatry Res 2009;168:259-261.
14. Tsuno N, Besset A, Ritchie K: Sleep and depression. J Clin Psychiatry 2005;66:1254-1269.
15. Roberts RE, Shema SJ, Kaplan GA, Strawbridge WJ: Sleep complaints in an aging cohort: a prospective perspective. Am J Psychiatry 2000;157:81-88.
16. Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E: Identifying an abnormal electroencephalographic sleep profile to characterise major depressive disorder. Biol Psychiatry 1997;41:964-973.
17. Souetre E, Salvati E, Rix H, Pringuey D, Krebs B, Ardisson JL, Darcourt G: Effects of recovery on cortisol circadian rhythms of depressed patients. Biol Psychiatry 1988;24:336-340.
18. Linkowski P: Neuroendocrine profiles in mood disorders. Int J Neuropsychopharmacol 2003;6:191-197.
19. Halbreich U, Asnis G, Shindledecker R, Zumoff B, Nathan RS: Cortisol secretion in endogenous depression. 2. Time related functions. Arch Gen Psychiatry 1985;42:909-914. (Pubitemid 16248517)
20. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Goldstein J, Copinschi G, van Cauter E: The 24-hour profile of adrenocorticotrophin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985;61:429-438. (Pubitemid 15243950)
21. Cassone VM, Warren WS, Brooks DS, Lu J: Melatonin, the pineal gland and circadian rhythms. J Biol Rhythms 1993;8: S73-S81.
22. Moore RY: Circadian rhythms. Ann Rev Med 1997;48:253-266.
23. Redman J, Armstrong S, Ng KT: Free-running activity rhythms in the rat: entrainment by melatonin. Science 1983;219:1089-1091.
24. Reiter RJ: Pineal melatonin: cell biology of its synthesis and of its physiological interaction. Endocr Rev 1991;12:127-132.
25. McIntyre IM, Norman TR, Burrows GD, Armstrong SM: Quantal melatonin suppression by exposure to light intensity light in man. Life Sci 1989;45:327-332.
26. Nathan PJ, Burrows GD, Norman TR: The effect of dim light on suppression of nocturnal melatonin in healthy women and men. J Neural Transm 1997;104:643-648.
27. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G: A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984;19:1215-1218.
28. Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, Ardisson JL, Darcourt G: Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989;28:263-278.
29. Nair N P, Hariharasubramanian N, Pilapil C: Circadian rhythm of plasma melatonin in endogenous depression. Prog Neuropsychopharmacol Biol Psychiatry 1985;8:715-718.
30. McIntrye IM, Judd FK, Norman TR, Burrows GD: Plasma melatonin concentrations in depression. Aust NZ J Psychiatry 1986;20:381-383.
31. Lam RW, Berkowitz AL, Berga SL, Clark CM, Kripke DF, Gillin JC: Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res 1990;33:129-134.
32. McIntrye IM, Burrows GD, Norman TR: Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans. Biol Psychiatry 1986;24:108-112.
33. Van Cauter E, Leclercq R, Vanhaelst L, Goldstein J: Simultaneous study of cortisol and TSH daily variations in normal subjects and patients with hyperadrenalcorticism. J Clin Endocrinol Metab 1974;39:645-652.
34. Kijne B, Aggernaes H, Fog-Mooler F, Harrestrup-Anderson H, Nissen J, Bjorum N, Kirkegaard C: Circadian variation of serum thyrotropin in endogenous depression. Psychiatry Res 1982;6:277-282.
35. Oren DA, Levendosky AA, Kasper S, Duncan CC, Rosenthal NE: Circadian profiles of cortisol, prolactin and thyrotropin in seasonal affective disorder. Biol Psychiatry 1996;39:157-170.
36. Halbreich U, Grunhaus L, Ben DH: Twenty four hour rhythm of prolactin in depressive patients. Arch Gen Psychiatry 1979;36:183-187.
37. Linkowski P, Van Cauter E, L'Hermite-Baleriaux M, Kekhofs M, Hubain M, Mendlewicz J: The 24-hour profiles of plasma prolactin in men with major endogenous depressive illness. Arch Gen Psychiatry 1989;46:813-823.
38. Jarrett DJ, Miewald J, Fedorke IB, Coble P, Kupfer DJ: Prolactin secretion during sleep: a comparison between depressed patients and normal control subjects. Biol Psychiatry 1987;22:1216-1226.
39. Rubin RT, Poland RE, Lesser IM, Martin DJ: Neuroendocrine aspects of primary endogenous depression. 5. Serum prolactin levels in patients and matched control subjects. Biol Psychiatry 1989;25:4-21.
40. Frangos E, Athanassenas G, Tsitourides S, Psilolignos P, Robos A, Katsanou N, Bulgaris Ch: Seasonality of the episodes or recurrent affective psychosis. J Affect Disord 1980;2:239-247.
41. Goodwin FK, Jamison KR: Manic Depressive Illness, ed 1. New York, Oxford University Press, 1980.
42. Cassidy F, Carroll BJ: Seasonal variation of mixed and pure episodes of bipolar disorder. J Affect Dis 2002;68:25-31.
43. Kraepelin E: Manic Depressive Insanity and Paranoia (transl RM Barclay). Edinburgh, Livingstone, 1921.
44. Bersani G, Garavani A: Melatonin add-on in manic patients with treatment resistant insomnia. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:185-191. (Pubitemid 30159528)
45. Plante DT, Winkelman JW: Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry 2008;165:830-843.
46. Bell LV: On a form of disease resembling some advanced states of mania and fever. Am J Insanity 1849;6:1079-1089.
47. Salvatore P, Ghidini S, Zita G, Panfilis C, Lambertino S, Maggini C, Baldessarini RJ: Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Dis 2008;10:256-265.
48. Mansour HA, Wood J, Chowdari K V, Dayal M, Thase ME, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL: Circadian phase variation in bipolar I disorder. Chronobiol Int 2005;22:571-584.
49. Wood J, Birmaher B, Axelson D, Ehmann M, Kalas C, Monk K, Turkin S, Kupfer DJ, Brent D, Monk T, Nimgaonkar VL: Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals. Psychiatry Res 2009;166:201-109.
50. Ashman SB, Monk TH, Kupfer DJ, Clark CH, Myers FS, Frank E, Leibenluft E: Relationship between social rhythms and mood in patients with rapid cycling bipolar disorder. Psychiatry Res 1999;86:1-8.
51. Sachar ED: Twenty-four hour cortisol secretory patterns in depressed and manic patients. Prog Brain Res 1975;42:81-91.
52. Akesode A, Hendler A, Kowarski A: A 24-hour monitoring of the integrated plasma concentration of aldosterone and cortisol in manic patients. Psychoneuroendocrinology 1976;1:419-426.
53. Linkowski P, Kerkhofs M, Van Onderbergen A, Hubain P, Copinschi G, L'Hermite-Baleriaux M, Leclerq R, Brasseur M, Mendlewicz J, Van Cauter E: The 24-hour profiles of cortisol, prolactin and growth hormone secretion in mania. Arch Gen Psychiatry 1994;51:616-624.
54. Cervantes P, Gelber S, Kin F N K, Nair V N P, Schwartz G: Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurocsci 2001;26:411-416.
55. Lewy AJ: Plasma melatonin in manic-depressive illness; in Usdin E, Kopin IJ, Barchas J (eds): Catecholamines: Basic and Clinical Frontiers. New York, Pergamom, 1979.
56. Kennedy SH, Kutcher SP, Ralevski E, Brown GM: Nocturnal melatonin and 24-h 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res 1996;63:219-222.
57. Norman TR: Melatonin: hormone of the night. Acta Neuropsychiatry 2009;21:263-265.
58. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA: Manic-depressive patients may be supersensitive to light. Lancet 1981; i: 383-384.
59. Lewy AJ, Nurnberger JI, Wehr TA, Pack D, Becker LE, Powell RL, Newsome DA: Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry 1985;142:725-727.
60. Nathan PJ, Burrows GD, Norman TR: Melatonin sensitivity to dim white light in affective disorders. Neuropsychopharmacology 1999;21:408-413.
61. Nurnberger JI, Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, Miller A, Bowman ES, Miller MJ, Rau NL, Smiley C, Davis-Singh D: Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry 2000;57:572-579.
62. Whalley LJ, Perini T, Shering A, Bennie J: Melatonin response to bright light in recovered, drug free, bipolar patients. Psychiatry Res 1990;38:13-19.
63. Hallam KT, Begg D P, Olver JS, Norman TR: Abnormal dose-response melatonin suppression by light in bipolar type I patients compared with healthy adult subjects. Acta Neuropsychiatry 2009;21:246-255.
64. King D P, Takahashi JS: Molecular genetics of circadian rhythms in mammals. Ann Rev Neurosci 2000;23:713-742.
65. Takahashi JS, Hong H-K, Ko CH, McDearmon EL: The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat RevGenet 2008;9:764-775.
66. Lowrey PL, Takahashi JS: Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Ann Rev Genomics Hum Genet 2004;5:407-441.
67. Lee C, Etchegaray JP, Cagampang ER, Loudon AS, Reppert SM: Post-translational mechanisms regulate the mammalian circadian clock. Cell 2001;107:865-867.
68. Mendlewicz J: Disruption of the circadian timing systems. Molecular mechanisms in mood disorders. CNS Drugs 2009;23(Suppl 2):15-26.
69. Ebisawa T, Uchiyama M, Kajimura N, Mishima K, Kamei Y, Katoh M, Watanabe T, Sekimoto M, Shibui K, Kim K, Kudo Y, Ozeki Y, Sugishita Y, Toyoshima R, Inoue Y, Yamada N, Nagase T, Ozaki N, Ohara O, Ishida N, Okawa M, Takahashi K, Yamauchi T: Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2001;2:342-346.
70. Takano A, Uchiyama M, Kajimura N, Mishima K, Inoue Y, Kamei Y, Kitajima T, Shibui K, Katoh M, Watanabe T, Hashimotodani Y, Nakajima T, Ozeki Y, Hori T, Yamada N, Toyoshima R, Ozaki N, Okawa M, Nagai K, Takahashi K, Isojima Y, Yamauchi T Ebisawa T: A missense variation in human caesin kinase I epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders. Neuropsychopharmacology 2004;29:1901-1909.
71. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, Ptacek L P, Fu Y-H: An hper2 phosphorylation site mutation in familial advance phase sleep syndrome. Science 2001;291:1040-1043.
72. Mansour HA, Monk TH, Nimgaonkar VL: Circadian genes and bipolar disorder. Ann Med 2005;37:196-205.
73. Lavebratt C, Sjoholm LK, Partonen T, Schalling M, Forsell Y: Per2 variation is associated with depression vulnerability. Am J Med Genet B Neuropsychiatr Genet 2010;153 B: 570-581.
74. Shiino Y, Nakajima S, Ozeki Y, Isono T, Yamada N: Mutation screening of the human period 2 gene in bipolar disorder. Neurosci Lett 2003;338:82-84.
75. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Seretti A, Colombo C, Smeraldi E: A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004;355:37-40. (Pubitemid 38077179)
76. Mansour HA, Wood J, Logue T, Chowdari K V, Dayal M, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL: Association study of eight genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 2006;5:150-157.
77. Nievergelt CM, Kripke DF, Barrett TB, Burg E, Remick RA, Sadovnick AD, McElroy SL, Keck PE, Schork NJ, Kelsoe JR: Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2006;141:234-241.
78. Severino G, Manchia M, Contu P, Squassina A, Lampus S, Ardau R, Chillotti C, Del Zompo M: Association study in a Sardinian sample between bipolar disorder and nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock. Bipolar Disord 2009;11:215-220.
79. Kishi T, Kitajima T, Ikeda M, Yamanochi Y, Kinoshita Y, Kawashima K, Okochi T, Ozaki N, Iwata N: Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorder in the Japanese population. Neurosci Res 2008;64:211-215.
80. Nievergelt C, Kripke DF, Remick RA, Sadovnick AD, McElroy SL, Keck PE, Kelsoe JR: Examination of the clock gene cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or association. Psychiatry Gen 2005;15:45-52.
81. Mansour HA, Talkowski ME, Wood J, Chowdari K V, McClain L, Prasad K, Montrose D, Fagiolini A, Friedman ES, Allen MH, Bowden CL, Calabrese J, El-Mallakh RS, Escamilla M, Faraone S V, Fossey MD, Gyulai L, Loftis JM, Hauser P, Ketter TA, Marangell LB, Miklowitz DJ, Nierenberg AA, Patel J, Sachs GS, Sklar P, Smoller J W, Laird N, Keshavan M, Thase ME, Axelson D, Birmaher B, Lewis D, Monk T, Frank E, Kupfer DJ, Devlin B, Nimgaonkar VL: Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord 2009;11:701-710.
82. Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, McMahon FJ, Gershon ES, Liu C: Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet 2008;147 B: 1047-1055.
83. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Hrishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, Vitaterna MH, Orsulak P, Takahashi JP, Nestler EJ, Carlezon WA, McClung CA: Mania-like behaviour induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007;104:6406-6411.
84. Tataroglu O, Aksoy A, Yilmaz A, Canbeyli R: Effect of lesioning the suprachiasmatic nuclei on behavioural despair in rats. Brain Res 2004;1001:118-124.
85. Tuma J, Strubbe JH, Mocaer E, Koolhaas JM: Anxiolytic-like action of the antidepressant agomelatine (S-20098) after a social defeat requires integrity of the SCN. Eur Neuropsychopharmacol 2005;15:545-555.
86. Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T: Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006;26:9022-9029.
87. Jope R, Roh MS: Glycogen synthase kinase-3 (GSK-3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 2006;7:1421-1434.
88. Uz T, Ahmed R, Akhisaroglu M, Kurtuncu M, Imbesi M, Dirm Arslan A, Manev H: Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 2005;134:1309-1316.
89. Campbell S, Macqueen G: The role of the hippocampus in the pathophysiology of depression. J Psychiatry Neurosci 2004;29:417-426.
90. Ogden C, Rich ME, Schork NJ, Paulus M P, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB: Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 2004;9:1007-1029.
91. Giedke H, Schwarzler F: Therapeutic use of sleep deprivation in depression. Sleep Med Rev 2002;6:361-377.
92. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A: Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long term remission rates. J Clin Psychiatry 2005;66:1535-1540.
93. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModerna A, Golshan S, Gillin JC, Potkin SG, Bunney WE: Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 2009;66:298-301.
94. Wirz-Justice A: Biological rhythms and depression: treatment opportunities. WPA Bull Depress 2008;13:5-8.
95. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jocobsen FM, Suppes T, Wisner KL, Nemeroff CB: The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005;162:656-662.
96. Lewy AJ, Lefler BJ, Emens JF, Bauer VK: The circadian basis of winter depression. Proc Natl Acad Sci USA 2006;103:7414-7419.
97. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E: Treatment of rapid cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry 1998;43:822-828.
98. Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock CA: A rapid-cycling bipolar patient treated with long nights, bedrest and light. Biol Psychiatry 1999;45:1075-1077.
99. Lewy AJ, Sack DA: Exogenous melatonin's phaseshifting effects of the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J Biol Rhythms 1997;12:588-594.
100. Dolberg OT, Hirschmann S, Grunhaus L: Melatonin for the treatment of sleep distubances in major depression Am J Psychiatry 1998;155:1119-1121.
101. Sprouse J: Pharmacological manipulation of circadian rhythms: a new drug target in psychotherapeutics. Exp Opin Ther Targets 2004;8:25-38.
102. Walton K, Fisher K, Rubitski D, Marconi M, Meng QJ, Sladek M, Adams J, Bass M, Chandrasekaran R, Butler T, Griffor M, Rajamohan F, Serpa M, Chen Y, Claffey M, Hastings M, Loudon A, Maywood E, Ohren J, Doran A, Wager TT: Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period. J Pharmacol Exp Ther 2009;330:430-439.
103. Lader M: Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target. Eur Neuropsychopharmacol 2007;17:743-755.
104. Sprouse J, Braseton J, Reynolds L: Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry 2006;60:896-899.
105. Klemfuss H: Rhythms and the pharmacology of lithium. Pharmacol Ther 1992;56:53-78.
106. LeSauter J, Silver R: Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol Psychiatry 1993;34:75-83. (Pubitemid 23240025)
107. Kaladchibachi SA, Doble B, Anthopoulos N, Woodgett JR, Manoukian AS: Glycogen synthase kinase 3, circadian rhythms and bipolar disorder: a molecular link in the therapeutic action of lithium. J Circadian Rhythms 2007;5:1-12.
108. Audinot V, Mailliet F, Lahaye-Brasseur C: New selective ligands of human cloned MT1 and MT2 receptors. Naunyn Schmiedebergs Arch Pharmacol 2003;367:553-561.
109. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D: The novel melatonin agonist agomelatine (S-20098) is an antagonist at 5HT2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 2003;306:954-964.
110. Redman JR, Guardiola-Lemaitre B, Brown M, Delagrange P, Armstrong SM: Dose-dependent effects of S-20098, a melatonin agonist on the direction of re-entrainment of rat circadian rhythms. Psychopharmacology 1995;118:385-390.
111. Goodwin GM: Clinical studies on the efficacy of agomelatine on depressive symptoms. CNS Drugs 2009;23(Suppl 2):35-39.
112. Kennedy SH: Agomelatine: efficacy at each phase of antidepressant treatment. CNS Drugs 2009;23(Suppl 2):41-47.
113. Grandin LD, Alloy LB, Abramson LY: The social zeitgeber theory, circadian rhythms and mood disorders: review and evaluation. Clin Psychol Rev 2006;26:679-694.
114. Aschoff J, Fatranska M, Giedke H, Doerr P, Stamm D, Wiser H: Human circadian rhythms in constant darkness: entrainment by social cues. Science 1971;171:213-215.
115. Frank E, Swartz A, Kupfer DJ: Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 2000;48:593-604.
116. Lustberg L, Reynolds CF: Depression and insomnia: questions of cause and effect. Sleep Med Rev 2000;4:253-262.
117. Harvey AG, Mullin BC, Hinshaw SP: Sleep and circadian rhythms in children and adolescents with bipolar disorder. Dev Psychopathol 2006;18:1147-1168.